Missing a trick? Bupropion for the pharmacological treatment of depression in the UK.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 40176479.
- Also identified by DOI 10.1192/bjp.2025.50.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bupropion is not licensed as an antidepressant in the UK, limiting its use. We highlight bupropion's distinct pharmacological profile and its potential benefits in treatment-resistant depression and people experiencing selective serotonin reuptake inhibitor-induced sexual dysfunction. The National Health Service repurposing medicines programme could improve equity of access for UK patients.
Medical subject headings
- Bupropion
- Depressive Disorder, Treatment-Resistant
- Antidepressive Agents, Second-Generation
- Sexual Dysfunction, Physiological